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Abstract Interesterification rearranges the position of fatty acids within triacylglycerols,
the main component of dietary fat, altering physical properties such as the
melting point and providing suitable functionality for use in a range of food
applications. Interesterified (IE) fats are one of a number of alternatives which
have been adopted to reformulate products to remove fats containing trans fatty
acids generated during partial hydrogenation, which are known to be detrimental
to cardiovascular health. The use of IE fats can also reduce the saturated fatty
acid (SFA) content of the final product (e.g. up to 20% in spreads), while
maintaining suitable physical properties (e.g. melt profile). A novel analysis was
presented during the roundtable which combined data from the UK National
Diet and Nutrition Survey (2012/2013–2013/2014) with expert industry
knowledge of the IE fats typically used in food products, to provide the first
known estimate of population intakes of IE fats among UK children and adults.
IE fats were found to contribute approximately 1% of daily energy across all
ages. The major contributors to overall IE fat intakes were fat spreads (~54%)
and bakery products (~22%), as well as biscuits (~8%), dairy cream alternatives
(~6%) and confectionery (~6%). Increasing use of IE fats could contribute
towards reducing total SFA intakes in the population, but would depend on
which food products were reformulated and their frequency of consumption
among sub-groups of the population. Studies comparing the effect of IE and non-
IE fats on markers of lipid metabolism have not shown any consistent
differences, either in the fasted or in the postprandial state, suggesting a neutral
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effect of IE fats on cardiovascular disease risk. However, these studies did not
use the type of IE fats present in the food supply. This issue has been addressed
in two studies by King’s College London, which measured the postprandial
response to a commercially relevant palm stearin/palm kernel (80:20) IE ‘hard
stock’, although again no consistent effects of the IE fat on markers of lipid
metabolism were found. Another study is currently investigating the same IE
hard stock, consumed as a fat spread (blended with vegetable oil), and will
measure a broader range of postprandial cardiometabolic risk factors. However,
further long-term trials using commercially relevant IE fats are needed.
Subsequent to the roundtable, a consumer survey of UK adults (n = 2062; aged
18+ years) suggested that there is confusion about the health effects of dietary
fats/fatty acids, including trans fats and partially hydrogenated fats. This may
indicate that providing evidence-based information to the public on dietary fats
and health could be helpful, including the reformulation efforts of food
producers and retailers to improve the fatty acid profile of some commonly
consumed foods.
Keywords: cardiovascular disease, fat metabolism, interesterified fats, postprandial
metabolism, saturated fatty acids, trans fatty acids
Introduction
Interesterification is a means of modifying the struc-
ture and functionality of fats and oils to produce food
ingredients for a range of applications, which can help
to reduce levels of saturated fatty acids (SFA) and
trans fatty acids (TFA) in some foods, by providing an
alternative to the use of animal fats or partially hydro-
genated oils, respectively. The use of interesterified
(IE) fats has increased in recent years, as part of the
ongoing reformulation initiative undertaken by food
manufacturers. A 1-day roundtable event was organ-
ised by the British Nutrition Foundation (BNF) and
King’s College London in March 2019 to discuss the
use of IE fats in the food chain, current understanding
as to their health effects, and recommendations for
future research and communication to key stakehold-
ers. This was arranged within the ‘Pathways to
Impact’ activities of a research grant awarded to
King’s College London and the Quadram Institute by
the Biotechnology and Biosciences Research Council
(BBSRC) Diet and Health Research Industry Club
(DRINC). Thought leaders from a range of fields,
including public health and academia, food retail,
manufacturing and technology, were invited to pro-
vide expertise and insight to the roundtable discussion.
This report provides a summary of the presentations
and discussions held at this roundtable meeting.
Cardiovascular disease (CVD) is a major public
health issue and accounts for 31% of all deaths glob-
ally (WHO 2017). In the UK alone, it is estimated
that over 7 million people are living with heart and
circulatory diseases (BHF 2019). There are several
established and emerging dietary and lifestyle risk fac-
tors for CVD. Among these, dietary fat composition
has long been considered as important (Sacks et al.
2017; Stanner & Coe 2019). For example, TFA pro-
duced by partial hydrogenation have also been shown
to adversely affect cholesterol levels and CVD risk
(Mozaffarian et al. 2006).
A diet containing foods high in SFA is associated
with a raised serum low-density lipoprotein cholesterol
(LDL-C) concentration (Sacks et al. 2017), which is a
causal risk factor for the development of atherosclero-
sis and CVD (Peters et al. 2016; Ference et al. 2017).
Dietary advice to reduce SFA intake in order to reduce
CVD risk has been established for a number of dec-
ades, although this advice has been challenged by
meta-analyses of prospective studies showing no rela-
tionship between SFA and the risk of coronary heart
disease (CHD; Siri-Tarino et al. 2010; Chowdhury
et al. 2014). However, a Cochrane systematic review
of 15 randomised controlled trials, involving almost
60 000 participants, concluded that reducing SFA
intake significantly reduced the risk of cardiovascular
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events by 17%. The review found greater reductions
(27%) in cardiovascular events in studies that replaced
SFA by polyunsaturated fatty acids (PUFA) than in
studies with replacement with carbohydrate (CHO) or
protein, where there was little evidence of any effect
(Hooper et al. 2015). These findings emphasise that
the nutrient replacing SFA in the diet is important.
Replacing SFA with cis configuration unsaturated fatty
acids (UFA), and especially PUFA, leads to a reduction
in serum LDL-C levels (Mensink 2016). In addition,
replacing SFA with UFA may also have benefits on
other risk factors including inflammation, endothelial
function and platelet activity (see Fig. 1; Stanner &
Coe 2019). Other factors which may also be impor-
tant determinants of the association between SFA and
CVD include the specific effects of different SFA on
lipid markers of CVD risk (some raise, while others
have a neutral effect on LDL-C and total cholesterol;
see Table 1; Mensink 2016). The influence of the food
matrix, within which SFA are found, is also impor-
tant; for example, milk and milk products contain sat-
urates but also contain additional constituents that
may result in such foods posing no risk for CHD or
even being protective (Buttriss & Coe 2019).
The recommendation to reduce the amount of SFA
in the diet was first included in US dietary guidelines
in 1961 (Page et al. 1961) and has been a core part of
national dietary guidelines in the UK since 1974
(COMA 1974). In response to public health recom-
mendations to reduce SFA intake, the use of partially
hydrogenated vegetable fats increased during the
Figure 1 The potential influence of dietary fat on risk factors for cardiovascular disease. Dietary triacylglycerol (TAG) is packed into chylomicron (CM) lipopro-
teins, which are hydrolysed in the circulation by the enzyme lipoprotein lipase (LPL) to release free fatty acids (FFA) and 2-monoaclyglycerol (2-MAG). Chylomi-
cron remnants (CMR) are taken up by the liver or may enter the artery wall and be taken up by macrophages to form ‘foam cells’, an important component of
an atherosclerotic plaque. Very-low-density lipoprotein (VLDL) is produced by the liver and subject to LPL hydrolysis to form low-density lipoprotein (LDL), or
the more atherogenic small dense LDL (sdLDL), which is more susceptible to oxidation and therefore uptake by macrophages. Inflammation may also act as a
mediator in the development of an atherosclerotic plaque. Flow-mediated dilatation (FMD) can measure the nitric oxide (NO)-mediated ability of the artery to
respond (dilate) to changes in blood flow. [Colour figure can be viewed at wileyonlinelibrary.com]
Table 1 Characteristics of some fatty acids commonly consumed
in dietary oils and fats and their effects on lipid markers
Saturated fatty acids
Lauric acid (12:0): the predominant fatty acid in coconut oil. Considered
to raise total, HDL- and LDL-cholesterol and lower TAG concentrations
Myristic acid (14:0): found particularly in coconut oil and milk fat.
Considered to raise total, HDL- and LDL-cholesterol and lower TAG
concentrations
Palmitic acid (16:0): the predominant fatty acid in palm oil, also found in
animal fats and coconut oil. Considered to raise total, HDL- and LDL-
cholesterol and lower TAG concentrations
Stearic acid (18:0): found particularly in meat and cocoa butter.
Considered to have a neutral effect on serum cholesterol and TAG levels
Unsaturated fatty acids
Oleic acid (18:1,n-9): the predominant fatty acid in olive oil, also found
in rapeseed oil. Considered to lower total and LDL-cholesterol
concentrations
Linoleic acid (18:2,n-6): the predominant fatty acid in sunflower oil, also
present in corn and soya bean oils. Considered to lower LDL-cholesterol
concentrations
Long-chain omega-3s (20:5,n-3;22:6,n-3): found in fish oils.
Considered to lower TAG concentrations
Sources: Mensink (2016); Abdelhamid et al. (2018). HDL, high-density
lipoprotein; LDL, low-density lipoprotein; TAG, triacylglycerol.
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1960s, 1970s and 1980s, to provide an alternative to
animal fats or tropical oils rich in SFA (Eckel et al.
2007). The process of partial hydrogenation alters the
physical properties of an oil high in UFA, increasing
its melting point and providing a firmer texture for
use in a range of applications (Munday & Bagley
2017). In part, the use of partial hydrogenation was
likely a reflection of the popularity of vegetable-
derived fats over animal-derived fats in terms of stabil-
ity, cost, availability and the unique properties these
fats could provide, for example, immediate spreadabil-
ity of margarine from the fridge, compared to the
hardness of butter (Eckel et al. 2007).
However, the negative cardiovascular health effects
associated with consuming oils containing TFA gener-
ated during the industrial partial hydrogenation pro-
cess are now widely recognised (Mozaffarian et al.
2006; SACN 2007). This has led to voluntary initia-
tives and regulatory measures in many countries to
decrease so-called ‘industrial’ TFA in the food chain
(Wanders et al. 2017). In the UK, voluntary measures
by the food industry have resulted in mean TFA
intakes in adults and children significantly decreasing.
In adults, TFA intakes were reported as 2.2% food
energy in 1986/1987, 1.2% in 2000 and further
decreasing to 0.5% food energy in 2014/2015–2015/
2016 (Gregory et al. 1990; Henderson et al. 2003;
Roberts et al. 2018), which is below the recommended
maximum for both the UK (<2% of dietary energy;
COMA 1994; SACN 2007) and internationally (<1%
of dietary energy; WHO 2018). The main dietary
source of TFA in the UK diet is now the naturally
occurring TFA present in foods derived from ruminant
animals – a product of the biohydrogenation process
in ruminants – which are considered to be of less con-
cern at the typical levels consumed in the diet (Gayet-
Boyer et al. 2014; de Souza et al. 2015).
In order to reduce ‘industrial’ TFA in foods, manu-
facturers have identified and adopted a number of sub-
stitutes for partially hydrogenated oils. The use of
modified fats and oils with different compositions and
desirable functionality and physical properties (e.g.
melt profile, solid fat content and crystal formation)
has allowed a reduction in the use of traditional ani-
mal fats from meat and dairy sources, thereby avoid-
ing the use of SFA-rich fats. One of these alternatives
is IE fats (Mills et al. 2017), which are now used in a
wide range of commonly consumed products (e.g. fat
spreads and cakes) in place of fats and oils higher in
SFA and ‘industrial’ TFA. Given their current use and
the potential to expand their usage further in reformu-
lation, it is timely to review current knowledge of the
use of IE fats in the food supply and findings from
human studies into their potential health effects.
Options for modification of dietary fats and
oils
In addition to interesterification, other fat modification
methods that avoid the use of partial hydrogenation
include blending, fractionation and full hydrogenation.
These approaches, summarised in Table 2, have
advantages and disadvantages, but, importantly, none
alone can deliver the range of functionalities to meet
the diverse food applications required by large-scale
food production and health-related reformulation
strategies.
What is interesterification and why is it
used?
In order to understand the process of interesterifica-
tion, a reminder of basic fat molecular structure is
useful. Triacylglycerol (TAG) is the predominant form
of dietary fat (~95%) and is composed of three fatty
acids esterified to a glycerol backbone (Fig. 2). Each
fatty acid can occupy one of three positions, which
are referred to using a stereospecific numbering system
(sn), with the two outer positions referred to as sn-1
and sn-3 fatty acids and the central position as the sn-
2 fatty acid. There are several determinants of the
physical and biochemical properties of a TAG mole-
cule, including the position (sn-1, sn-2 or sn-3) of its
component fatty acids, as well as the chain length of
the fatty acids, their degree of saturation (number of
double bonds) and their configuration (cis or trans).
The term ‘molecular species’ is often used to
describe the exact type and position of fatty acids
within a TAG molecule. A TAG molecule which only
contains SFA palmitic acid (P) and unsaturated oleic
acid (O) can have up to eight potential TAG molecu-
lar species (POO, POP, OOP, OPO, PPO, OPP, PPP
and OOO). Interestingly, plant and animal oils/fats
typically differ in the position of UFA and SFA on the
glycerol backbone; in plant fats, SFA tend to be
attached to the outer sn-1 and sn-3 positions, whereas
animal fats contain a greater proportion of SFA in the
sn-2 position (Fig. 3). For example, palm oil predomi-
nantly contains TAG molecular species with saturated
palmitic acid in the sn-1 and sn-3 positions and unsat-
urated oleic acid in the sn-2 position. However, in
lard, the majority of sn-2 position fatty acids are pal-
mitic acid, with the greatest proportion of sn-1 and
sn-3 positions occupied by oleic acid (Berry 2009).
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 363–380
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Table 2 A comparison of the advantages and disadvantages of natural and modified fats and oils (information presented at the Roundtable
on Interesterified Fats in Foods)
Type of fat or oil Description Advantages Disadvantages
Animal fats Examples include:
• lard
• beef tallow
• Perceived as ‘natural’
• Semi-solid at room temperature
• Product not suitable for
vegetarians, vegans or other
specific dietary requirements (e.g.
halal and kosher)
• May be higher in SFA than
vegetable fats
• Off flavours which affect taste
Dairy fats Examples include:
• butter
• milk fat/cream
• Desirable melt profile for some
applications
• Price (5–8 times more expensive
than vegetable oil)
• Not suitable for all applications
(low melting temperature)
• Product not suitable for vegans
• Typically higher in SFA than most
vegetable oils/fats
Interesterified fat Rearranges the fatty acid composition
of TAG, the predominant form of
dietary fat, to alter the solid fat
content and melt profile
• Does not generate TFA
• IE fats can be blended with oils for
use in a wide range of applications
• Avoids use of alternative fats
higher in SFA
• Potential equipment set-up/running
costs
Partially hydrogenated oil Partially hydrogenated oils are defined
as oils that have been
hydrogenated, but not to complete
or near-complete saturation (i.e.
double bonds are hydrogenated or
converted from a cis to trans
configuration)
• Uses cheaper vegetable-based oils
with a lower SFA content than
animal-derived alternatives
• Provides fats with a wide range of
functionality
• Generates TFA during the
hydrogenation process, which
remain in the oil as the
hydrogenation process is
incomplete
• Production requires use of metal
catalysts
Fully hydrogenated oil Full hydrogenation of vegetable oils
produces fats in which all the fatty
acids are fully saturated with
hydrogen. Such fats on their own
are too waxy and solid to use in
many food production applications
• No TFA present in the final
product (unlike PHOs)
• Can use locally sourced oils (e.g.
rapeseed oil)
• Can be stearic acid-rich (neutral
effect on LDL-C) if derived from
oils such as rapeseed or soya oils
that are rich in 18-carbon fatty
acids
• Poor textural qualities (e.g. does
not melt in the mouth)
• May be higher in some SFA that
have adverse CVD health effects
(see Table 1)
• Consumer resistance to products
with ‘hydrogenated’ on food label
• Manufacturing difficulties due to
high melting points (above 80°C)
• Production requires use of metal
catalysts
Blended oils Different base stocks are mixed
together to obtain a specific
composition, consistency and/or
stability in the final product
• Cost-effective
• Good consumer acceptance
• Oils used have a higher SFA
content than IE equivalents
• Crystallisation properties may not
always be ideal
Fractionated oils Separates fats and oils into two or
more fractions (e.g. palm olein and
palm stearin from palm oil) with
different melting points. The palm
oil industry uses fractionation to
alter and extend the functionality
of palm oil for use in different food
and feed applications
• Most fractionations do not require
use of additional chemicals
• All fractions are used and enter
food supply chain – no decrease
in overall SFA consumption at a
population level
• Poor crystallisation properties that
affect product stability (e.g.
‘blooming’ of fat)
CVD, cardiovascular disease; IE, interesterified; LDL-C, low-density lipoprotein cholesterol; PHO, partially hydrogenated oil; SFA, saturated fatty acids; TAG, tria-
cylglycerol; TFA, trans fatty acids.
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The term interesterification refers to a chemical or
enzymatic process that rearranges the fatty acids on
the glycerol backbone of a TAG molecule, in either a
random or a specific way. The altered proportions of
TAG molecular species that result from rearrangement
can confer useful functional characteristics, including
a higher melting point and altered crystalline struc-
ture, and typically increases the solid content of a fat.
Position-specific enzymatic interesterification can also
be used to create infant formula products with specific
TAG molecular species, which mimic the composition
of human breastmilk and may aid fat absorption
(Spurgeon et al. 2003).
Chemical interesterification typically uses sodium
methoxide as the catalyst and involves hydrolysis and
random redistribution of all fatty acids within a TAG
mixture. Chemical interesterification has been in com-
mercial use since the 1940s, when it was used to mod-
ify the solid fat content of lard as a means of
improving its spreadability and baking properties
(Mensink et al. 2016). It remains the main form of
interesterification used in the UK.
Enzymatic interesterification uses microbially
sourced lipase enzymes (e.g. from Candida rugosa)
and gives either a random or specific redistribution of
fatty acids, depending on the specificity of the lipases
used (Mensink 2016). Enzymatic interesterification
was first developed in the early 1980s to provide a
cheaper source of confectionery fat to replace cocoa
butter, by modifying the TAG molecules within palm
oil (Dayton 2014) and has subsequently become the
predominant interesterification method used in the US
and Canada. While enzymatic interesterification may
have lower equipment costs than chemical interesterifi-
cation, it requires the use of a more expensive catalyst
(lipase enzyme compared to sodium methoxide). How-
ever, enzymatic methods can be carried out at lower
operating temperatures, lead to lower neutral oil losses
and preserve the oxidative stability of the resulting
product (Rousseau & Marangoni 2002).
As well as differences between the US and the UK
in the methods employed for interesterification, differ-
ent oils are used in the preparation of IE fats, which
reflect those commonly used in the food supply. In the
US, stearic acid-rich IE fats (soybean oil-based) are
used for many products such as baked goods, whereas
in Europe palmitic acid-rich fats (palm oil-based) are
more common for these applications. Within both
Europe and the US, palmitic acid- and lauric acid-rich
IE fats are generally used for spreads, due to their
enhanced melting properties (see Table 1 for informa-
tion about these individual fatty acids). In the UK, for
example, combinations of palm oil fractions (palm
kernel and palm stearin) are used to produce an IE
hard stock, which can then be blended at varying
ratios with a liquid oil (e.g. rapeseed oil) to achieve
the desired functional properties (Mills et al. 2017).
Key sensory characteristics of the final fat blend,
such as the ‘mouthfeel’, are determined by the melt
profile, which reflects the solid fat content at different
temperatures. Blending IE fats with liquid oils not
only allows suitable functionality but, perhaps more
importantly from a health perspective, also results in a
final product with a lower SFA content. As an illustra-
tion, combining 75% IE palm oil with a liquid oil
(e.g. rapeseed) can achieve the same melt profile as
‘native’ palm oil, while reducing the SFA content by
20% (Fig. 4).
How much interesterified fat do we eat in
the UK and in which foods is it present?
IE fats are now being used around the world in the
manufacture of a range of products, in place of TFA-
containing fats, yet there is currently no published
estimate of their intake from the UK diet. Assessing
intake is not straightforward, requiring specialist
knowledge, as many IE fats used commercially are
blended with other unmodified oils prior to use.
Figure 2 General structure of a triacylglycerol (TAG) molecule. Fatty acids
(R1, R2 and R3) vary in their length and degree of unsaturation at each of
the three stereospecific positions (sn-1, sn-2 and sn-3). The shaded area
represents the glycerol ‘backbone’ of the molecule. [Colour figure can be
viewed at wileyonlinelibrary.com]
Figure 3 Example of the typical positional arrangement of saturated and
unsaturated fatty acids within TAG from plant- (a) and animal-derived fats
(b). Based on information from Berry (2016). [Colour figure can be viewed
at wileyonlinelibrary.com]
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Laboratory analysis can determine the positional com-
position of the TAG components of a fat, although it
may not be possible to quantify what proportion has
undergone interesterification and how much is from
unmodified oil added to the blend.
To date, the best available estimate of IE intakes
has been in the US population and employed mod-
elling methods using dietary intake data from the US
National Health and Examination Survey (NHANES).
This analysis forecasted the potential IE fat intake if
palm-based oils (some of which may be IE), or an IE
fat made with fully hydrogenated soybean oil, were
used as functional replacements for TFA-containing
oils in 12 food categories included in the NHANES
survey (Mensink 2016). It was estimated that such a
scenario would result in an IE fat intake of approxi-
mately 3% of daily energy. However, this modelling
approach is less helpful in the UK and other European
countries because TFA-containing fats in the food sup-
ply have already been partly replaced with palmitic
acid-rich IE fats.
During the roundtable, a new detailed analysis was
presented, which used a novel methodology to esti-
mate current IE fat intakes in the UK population for
the first time (unpublished data: J. H. Bruce, S. E.
Berry & W. L. Hall). The analysis combined data
from the National Diet and Nutrition Survey (NDNS)
with expert industry knowledge of commercially rele-
vant IE fats and their use. The NDNS programme is a
continuous, cross-sectional survey designed to collect
detailed, quantitative information on the food con-
sumption of the general population living in private
households in the UK (Bates et al. 2016). Food diary
intake data from Years 5 to 6 of the NDNS Rolling
Programme (2012/2013 and 2013/2014) for children
and adults (aged 1.5 years and over) were used, the
latest raw data that were available at the time of com-
mencing the analysis. A total of 391 foods likely to
contain IE fats were identified from the survey data.
By applying expert industry knowledge about the type
and amount of IE fat blends typically used for each
food type (32 potential formulations), it was possible
to estimate an IE fat content per 100 g of fat in each
case. Using this procedure, a total IE fat intake per
day (percentage of energy) was calculated (shown by
quartiles of intakes; Fig. 5), as well as the main food
groups contributing to IE fat intakes (Fig. 5).
Mean IE fat intake was estimated to be 1.1% (95%
CI 0–3.45 %) of daily energy intake in the UK diet
(unpublished data: J. H. Bruce, S. E. Berry & W. L.
Hall), which equated to a mean (95% CI) IE fat
intake of 2.2 g/day (0–6.9 g). In comparison, data for
fat intakes from NDNS for adults (aged 19–64 years)
were as follows: total fat 67.8 g/day (25.7 g/day);
SFA 25.2 g/day (10.8 g/day); and TFA 1.0 g/day
(0.5 g/day). Those in the highest quartile of intakes
obtained a mean 2.4% of energy from IE fats, relative
to a mean of only 0.1% of daily energy for people in
the lowest quartile of consumption (Fig. 5).
The NDNS analysis revealed that the largest food
contributor to IE fat intakes was fat spreads, which
provided approximately 54% of the total IE fat con-
sumed across all age groups combined (Fig. 6a). Other
Figure 4 Change in the percentage of solid fat with temperature in three
oils. Palm oil (PO); interesterified palm oil (IEPO); IEPO blended with liquid
oil (75% IEPO). (Unpublished data: J. H. Bruce, S. E. Berry & W. L. Hall).
[Colour figure can be viewed at wileyonlinelibrary.com]
Figure 5 Daily contribution of interesterified (IE) fats to total energy
intake (%) for adults and children (aged 1.5 years and over) by quartiles
(Q) of IE fat intake using data from the National Diet and Nutrition
Survey (Years 5 and 6, 2012/2013 and 2013/2014), Bates et al. (2007).
(Unpublished data: J. H. Bruce, S. E. Berry & W. L. Hall) More details
regarding the data analysis can be requested from the corresponding
author. [Colour figure can be viewed at wileyonlinelibrary.com]
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key dietary sources of IE fats were cakes, pastries and
bakery goods, contributing approximately 22% of IE
fat intake, as well as biscuits (~8%), confectionery
(~6%) and dairy cream alternatives (~6%) (unpub-
lished data: J. H. Bruce, S. E. Berry & W. L. Hall).
Considering that particular types of IE fats are used
for certain food applications (e.g. palmitic/lauric acid-
rich IE palm oil, blended with vegetable oil, for fat
spreads), it is perhaps not surprising that the propor-
tion of IE fat types consumed in the diet reflected the
foods in which they are used (Fig. 6a,b). Thus, the
highest intakes were of palmitic/lauric IE fats (in fat
spreads; around 55%), followed by palmitic/oleic IE
fats (in bakery products; 30%), with high lauric IE
fats (in buttercream-like fillings, confectionery fillings
and chocolate alternatives) comprising the remainder
of the IE fat consumed. The data suggest that higher
occupational social class may be associated with lower
IE fat intakes, but further analysis is required to con-
firm this.
It is interesting to note that there are strict Euro-
pean regulations (reflected in UK law) determining the
type of fats permitted for use in chocolate. Aside from
a minimum percentage of cocoa butter requirement,
only six types of vegetable fats (illipe, palm oil, sal,
shea, kokum gurgi and mango kernel) are authorised
for use and must be obtained only by the processes of
refining, fractionation or both, which excludes enzy-
matic (or chemical) modification of the TAG structure
(HMSO 2003). Therefore, IE fats may not be used in
chocolate but can be used for chocolate-flavoured con-
fectionery fillings or coatings.
Although the UK government’s reformulation drive
in the last few years has focused largely on sugar
reduction, the Scientific Advisory Committee on Nutri-
tion (SACN) report ‘Saturated fats and health’ pub-
lished this month (https://www.gov.uk/government/
publications/saturated-fats-and-health-sacn-report)
draws attention to the importance of reducing the SFA
content of food products. One of the important
considerations, discussed by the roundtable partici-
pants, was the role that IE fats have already begun to
play in reducing SFA and ‘industrial’ TFA intakes in
the UK and elsewhere, and the potential to further
reduce SFA by wider use in the food chain.
A modelling exercise (unpublished data: J. H. Bruce,
S. E. Berry & W. L. Hall) was undertaken to consider
the impact of replacing IE fats with the best available
non-IE options (e.g. fractionation and blending; see
Table 2), for each application that is currently using
IE fats/oils. As shown in Figure 7, this predicted that
the SFA content, as a percentage of total fat, would
increase by 11.1 percentage points for fat spreads, 9.2
percentage points for bakery products and 15.7 per-
centage points for confectionery. The estimated effect
of these changes, based on consumption data from the
same NDNS data set, would be to slightly increase
total SFA intake in the population (all ages) from
approximately 12.7% to 13.1% of food energy. How-
ever, it is likely that the increase in SFA intake would
be greater for the highest IE fat consumers.
While removing IE fats from foods and replacing
them with non-IE alternatives might increase SFA
Figure 6 Percentage contribution of different food categories (a) and types of interesterified (IE) fat (b) to overall IE fat intakes among adults and children
(1.5 years and over), using data from the National Diet and Nutrition Survey (Years 5 and 6, 2012/2013 and 2013/2014), Bates et al. (2007). (Unpublished
data: J. H. Bruce, S. E. Berry & W. L. Hall). [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 7 Estimated effect on saturated fatty acid (SFA) intakes of removing
interesterified (IE) fats from foods and replacing these fats with non-IE fats
(unpublished data: J. H. Bruce, S. E. Berry & W. L. Hall, presented at Round-
table on Interesterified Fats in Foods). More details regarding the data analysis
can be requested from the corresponding author.
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intakes in the population, the greater use of IE fats
(e.g. as part of a reformulation strategy) could have
the opposite effect and further reduce SFA in certain
products. A further modelling analysis was performed,
again using expert industry knowledge, which esti-
mated that maximising the use of IE fats could reduce
the SFA content of biscuits from 47.2% to 36.6%
(10.6 percentage point reduction). In terms of other
food categories, greater use of IE fats has the potential
to reduce the SFA content of cakes and shortcrust pas-
tries from approximately 42% to 35% (of total fat),
with little or no change achievable for puff pastry,
spreads or confectionery (unpublished data: J. H.
Bruce, S. E. Berry & W. L. Hall). The overall effect
these changes could have on population SFA intakes
would depend on how the amount and frequency of
consumption of these products vary among different
groups within the population. In this context, it is
important to review the research into the effects of IE
fats on health, both in the short- and in the long-term,
as is discussed in the next section.
What are the health effects of
interesterified fats?
The association between SFA, TFA, PUFA and
monounsaturated fatty acids has been studied in rela-
tion to CVD risk, and their effects on serum lipopro-
teins have been evaluated (Mensink et al. 2003, 2016;
Mozaffarian et al. 2006). However, the health effects
of IE fats, especially those that are commonly used by
the food industry, are less well studied.
Interesterification involves positional changes of
fatty acids on the glycerol backbone. As a result, while
the total fatty acid composition of an IE fat is identi-
cal to that of a non-IE fat, the sn-positional composi-
tion and physical characteristics are different. The
cardiovascular effects of different IE fats are likely to
be influenced not only by the particular fatty acid
composition of the IE fat, but also by the melting
point and the percentage of SFA at the sn-2 position
of TAG, which may influence their absorption and
subsequent metabolism (Berry 2009).
It is thought that differences in sn-positional compo-
sition between some animal and plant fats may
explain their divergent effects on atherogenesis (the
formation of fatty plaques in the arterial wall; see
Fig. 1), despite having a similar SFA content. For
example, in palm oil, SFA make up 49% of the total
fat and are mainly present in the sn-1 and sn-3 posi-
tions of TAG molecules (only 10% of palmitic acid is
found in the sn-2 position; Filippou et al. 2014b).
However, in lard, although the SFA content is similar
(44% of total fat), a greater proportion of the SFA are
located in the sn-2 position (71% of palmitic acid;
Filippou et al. 2014a).
The pancreatic lipases which digest dietary TAG
preferentially release fatty acids attached to the sn-1
and sn-3 positions of TAG, giving two free fatty acids
and a molecule of 2-monoacylglycerol (Yang & Kuk-
sis 1991), which are then absorbed. Commonly con-
sumed SFA (e.g. palmitic and stearic acids) may be
better absorbed when they are retained within 2-
monoacylglycerol during digestion, which has been
shown in studies of rats (Brink et al. 1995) and
human infants (Carnielli et al. 1996). Following diges-
tion and absorption, 2-monoacylglycerol is used to re-
synthesise TAG, which is then released into the circu-
lation within chylomicron lipoproteins. Circulating
TAG containing a higher proportion of sn-2 SFA may
not be cleared from circulation as efficiently (Mor-
timer et al. 1988) and may lead to the accumulation
of smaller chylomicron ‘remnants’ (Mortimer et al.
1990), which are implicated in forming atherosclerotic
plaques (Karpe et al. 1994; Pal et al. 2003; Botham
2008). Furthermore, SFA attached to the sn-2 position
may be more likely to be transported to the liver,
rather than stored in adipose tissue, which may elevate
LDL concentrations (West & Fernandez 2005). There-
fore, as interesterification of plant oils typically
increases the proportion of SFA in the sn-2 position, it
has been suggested that IE fats may have adverse
effects on lipid metabolism and CVD risk.
Feeding studies conducted in both rabbits (Kritch-
evsky et al. 2000a, 2000b) and mice (Afonso et al.
2016) have reported more severe atherosclerosis when
animals were given diets with IE palm oil, containing
more sn-2 palmitic acid, compared to native palm oil.
However, due to the practical and cost implications of
conducting such studies in humans, research to date
has instead focused on lipid markers (e.g. LDL and
total cholesterol) of CVD risk. Several human studies
have investigated the effects of consuming IE fats for
3–6 weeks on fasting measures of blood lipids [total
cholesterol, high-density lipoprotein cholesterol (HDL-
C) and LDL-C; TAG], in comparison with non-IE
equivalents. None of these studies reported any signifi-
cant effect when participants consumed IE palm oil
(Zock et al. 1995; Nestel et al. 1998; Filippou et al.
2014b), IE shea butter (Berry et al. 2007a), IE butter
(Christophe et al. 2000), IE lard (Shane et al. 1999)
or an IE blend of fats (Meijer & Weststrate 1997), rel-
ative to a native test fat equivalent. It is possible,
though, that the relatively short duration of these
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 363–380
Interesterified fats in foods 371
trials and the limited number of subjects may have
been insufficient to detect a significant effect on fasting
lipid profile. In addition, the IE fats used in these stud-
ies are not those used commercially.
While measuring fasting lipid parameters provides
some useful information, most humans eat several
times a day and spend the majority of their time in
the postprandial (fed) state. An elevated postprandial
lipaemia (as indicated by the size or duration of the
increase in plasma TAG concentrations following a
meal) is associated with an increased risk of car-
diometabolic disease, which includes CHD (Eberly
et al. 2003; Bansal et al. 2007). Other than the influ-
ence on lipoprotein re-modelling, postprandial lipae-
mia may also increase CHD risk through oxidative
stress, inflammation, haemostatic perturbations and
endothelial dysfunction (Marchesi et al. 2000; Bae
et al. 2001). Thus, determining the postprandial
response to different dietary fats may be a more
important tool for predicting cardiometabolic risk
than fasting lipid concentrations.
A number of studies have been performed to assess
whether interesterification may adversely affect post-
prandial lipid or glucose metabolism, although the
results have not indicated any detrimental effects (see
Table 3). While some acute studies have suggested a
neutral effect on postprandial lipaemia, glucose and/
or insulin concentrations (Zampelas et al. 1994; Sum-
mers et al. 1998, 1999; Yli-Jokipii et al. 2003; Filip-
pou et al. 2014b), other studies have reported a
reduced postprandial TAG response to an IE test fat
(Yli-Jokipii et al. 2001; Sanders et al. 2003, 2011;
Berry et al. 2007b; Robinson et al. 2009; Hall et al.
2014). The inconsistency in these postprandial effects
reported in studies was discussed at the roundtable. A
plausible explanation raised was the suggestion that
the solid fat content may be a more important deter-
minant of the digestion and metabolic handling of a
fat than the positional composition (the proportion of
fatty acids at the sn-2 position; Berry 2009). Different
TAG molecular species (e.g. POP vs. PPO) appear to
be digested and metabolised at similar rates in
humans. However, TAG species in which interesterifi-
cation imparts marked differences in physical charac-
teristics are likely to form micelles less readily, which
may slow their rate of digestion and absorption in
the intestine.
A key limitation of the postprandial studies of IE
fats described in Table 3 is that the IE fats tested were
not representative of those that are used commercially
and that are present in the food chain, therefore limit-
ing the public health relevance of the findings. To
address this issue, researchers from King’s College
London conducted two studies to investigate the
effects on postprandial lipid metabolism of a com-
monly consumed IE hard stock (the hard fat that is
blended with other oils/fats) consisting of a blend of
IE palm stearin and palm kernel oil. The findings from
these studies were presented and discussed at the
roundtable. In the first study, a palm stearin/palm ker-
nel (80:20) hard stock, which was either IE (55% pal-
mitic acid in sn-2) or unmodified (36% palmitic acid
in sn-2), was baked into muffins to provide 50 g of
each test fat on two separate occasions (Hall et al.
2017). The muffins were identical in composition
except for the type of fat used and were given as part
of a test meal, which also included custard and a
milkshake [832 kcal total energy; 15 g protein (7%
energy); 81 g carbohydrate (37% energy); and 52 g
fat (56% energy)]. In the 12 healthy men studied,
there was a significantly greater incremental area
under the curve (iAUC) TAG (a measure of the plasma
TAG response to the test meal over time; 51% higher)
after the IE fat than the non-IE fat. However, the pat-
tern of lipaemia differed in response to the two test
meals, with plasma TAG levels declining 4 hours after
the meal containing IE fat, whereas they continued to
rise until the end of the study period following the
non-IE fat test meal. Therefore, despite the greater
TAG excursion after the IE palm stearin/palm kernel
hard stock, it is possible that values may have
returned to baseline more rapidly than for the non-IE
hard stock.
In the recently completed InterMet study (Clini-
calTrials.gov Identifier: NCT03191513), Mills and
colleagues tested the same commercially relevant
hard stock palm fats, either IE or non-IE, to investi-
gate 8-hour metabolic responses (measured hourly)
to a single test meal containing these fats, thus pro-
viding novel information on the acute effects of com-
mercially relevant IE fats on postprandial lipaemia
(Berry et al. 2018). Healthy subjects (n = 20; males
and females; aged 45–75 years) consumed test meals
(muffin and a milkshake; 897 kcal; 50 g fat; 16 g
protein; 88 g carbohydrate), which again provided
50 g of the test fat on each occasion. A meal con-
taining a reference fat (rapeseed oil), which was
known to elicit a pronounced postprandial lipaemic
response, was also tested as a comparator. In con-
trast to the hypothesis, there was no difference
between the IE and non-IE hard stocks noted in
postprandial lipaemia values measured at 4 hours
(time of peak lipaemia) or 8 hours (reflecting the
efficiency of TAG-rich lipoprotein clearance), nor for
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iAUC values over the 8-hour period. Lipoprotein
particle size and number were also determined, and,
similarly, no significant differences were found
between the IE and non-IE test fats. The results from
this study, in addition to the evidence already dis-
cussed, do not indicate a negative effect of IE fat
consumption on fasted or postprandial markers of
cardiometabolic risk.
Despite the apparently neutral postprandial lipaemic
response after acute consumption of IE palm-based
fats consumed as hard stocks, there may still be differ-
ences in postprandial lipaemia and other car-
diometabolic risk indicators, such as vascular
function, when comparing IE fat-containing products
available off the shelf with functional alternatives. For
example, commercially, the palm stearin/palm kernel
Table 3 Summary of studies investigating the postprandial effects of interesterified fats
Study Subjects and duration Test fat used Postprandial effects
Hall et al. (2014) 11 males (40–70 years; BMI 20–
35 kg/m2), 6-hour period
75 g of native PO or IPO Lower plasma TAG response during
first 4 hours for IPO test meal vs.
PO test meal, no overall
differences during 6-hour period
Filippou et al. (2014a) 25 males and 25 females (18–
45 years; BMI 20–35 kg/m2), 2-
hour period
50 g of high oleic sunflower oil
(control), PO, IPO or lard
No differences in response between
four test meals for plasma glucose,
insulin or C-peptide
Sanders et al. (2011) 25 males and 25 females (18–
45 years; BMI 20–35 kg/m2), 8-
hour period
50 g of high oleic sunflower oil
(control), PO, IPO or lard
Lower plasma TAG response for IPO
vs. PO or control
Robinson et al. (2009) 11 obese males (mean age
59.3  1.8 years; BMI >30 kg/m2)
and 10 non-obese males
(55.8  2.2 years; BMI >30 kg/m2),
6-hour period
1 g fat/kg body mass blend of non-IE,
CIE or EIE sunflower oil/canola
stearin
Greater plasma TAG response with
CIE vs. NIE in obese subjects. No
other differences
Berry et al. (2007b) 20 males (18–60 years; BMI 20–
35 kg/m2), 6-hour period
50 g of native PO or IPO Lower plasma TAG (at 1, 2, 5 and
6 hours) and insulin response (at
30, 90 and 120 minutes) after IPO
vs. PO
Berry et al. (2007a) 16 males (mean age
26.8  8.0 years; mean BMI
23.7  3.7 kg/m2)
3 weeks of diet containing 30 g of
native or IE shea butter followed
by postprandial assessment of
response to 50 g of native or IE
shea butter
No differences in plasma TAG, insulin
or glucose response
Yli-Jokipii et al. (2003, 2004) 2 males and 7 females, 8-hour period 55 g of native or IE lard per square
metre body area
Almost significantly lower TAG after
IE lard vs. native lard
Sanders et al. (2003) 17 males (mean age
38.2  11.1 years; mean BMI
24.5  2.9 kg/m2), 6-hour period
50 g of native or IE cocoa butter Lower plasma TAG response and
lower factor VIIa concentrations
after IE vs. native cocoa butter
Yli-Jokipii et al. (2001) 10 females (18–45 years; BMI 18.5–
25 kg/m2), 6-hour period
55 g of native or IE lard per square
metre body area
Lower plasma TAG response after IE
vs. native lard
Summers et al. (1999) 14 females (29–70 years; BMI 20.6–
52.8 kg/m2), 6-hour period
60 g of native (67% oleic acid in sn-
2) or EIE fat (83% stearic acid in
sn-2)
No differences in plasma TAG,
VLDL-TAG, CM-TAG, glucose or
insulin responses
Summers et al. (1998) 2 males and 6 females, 6-hour period 60 g of native (6% palmitate in sn-2)
or EIE fat (68% palmitate in sn-2)
No differences in plasma TAG,
VLDL-TAG, CM-TAG, glucose or
insulin
Zampelas et al. (1994) 16 males, 6-hour period 40 g of IE blend (palm stearin with
sunflower and high oleic acid
sunflower oils) or ‘native’ vegetable
oil
No differences for CM-TAG, glucose
or insulin
Mean values are SD. BMI, body mass index; CIE, chemically interesterified; CM, chylomicron; EIE, enzymatically interesterified; IE, interesterified; IPO, interester-
ified palm oil; NIE, non-interesterified; PO, palm oil; TAG, triacylglycerol; VLDL, very-low-density lipoprotein.
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(80:20) hard stock is often blended with other unmod-
ified vegetable oils (e.g. rapeseed) in varying propor-
tions to meet a desired functionality of the end
product (e.g. 20% solids at 20°C but only 3% solids
at 35°C). The postprandial effect of IE fat blends
within widely available products is currently being
explored by researchers at King’s College London, in
a further randomised controlled double-blinded study.
The ongoing InterCardio study (ClinicalTrials.gov
Identifier: NCT03438084) aims to investigate differ-
ences in the acute cardiovascular risk response to a
widely consumed spread containing IE fat, vs. other
non-IE functional equivalents, using multiple biomark-
ers of CVD risk. In this intervention study, 50 healthy
subjects (male and female) are being recruited to con-
sume test meals containing typical retail spreads com-
posed of either IE fats or other non-IE functional
equivalents (50 g of each fat), spreadable butter, a
non-IE fat equivalent spread and rapeseed oil as the
reference fat. In addition to postprandial TAG concen-
trations, this study will assess vascular function,
oxidative stress and inflammatory responses over an 8-
hour period. Results of this study will increase under-
standing of the effects of IE fats on a broader range of
cardiovascular risk markers and will help determine
whether longer-term chronic dietary intervention stud-
ies are needed to fully understand the potential impact
on atherosclerosis and cardiometabolic disease risk.
Recommendations for future research
Present knowledge suggests a neutral effect of IE fats
on cardiovascular health, but there are research gaps
which need to be addressed. Considerations for future
studies on the metabolic effects of IE fats were high-
lighted in a previous expert workshop convened by
the International Life Sciences Institute (Mensink et al.
2016) and were also discussed at the roundtable
(Table 4). Some of the considerations listed in Table 4
reflect advances in our understanding of the breadth
of factors which determine overall cardiometabolic
risk. In addition to effects on lipid metabolism, this
includes consideration of glucose metabolism and
insulin sensitivity, as well as inflammatory (e.g. C-re-
active protein), oxidative stress and haemostatic mark-
ers (e.g. tissue plasminogen activator). In particular,
chronic studies of longer duration using commercially
relevant IE fats, of the type and amount typically con-
sumed by the population, are needed. Observational
studies investigating the relationship between popula-
tion IE fat intakes and health outcomes will also add
insight.
Many of the considerations mentioned in Table 4
have been incorporated into the design of the afore-
mentioned InterCardio study, including a detailed
assessment of the postprandial lipaemic response to
test fats (e.g. TAG concentrations; chylomicron fatty
acid composition; lipoprotein particle size; and num-
ber, see Fig. 1), as well as markers of vascular func-
tion (e.g. flow-mediated dilatation to measure nitric
oxide-mediated endothelial function; plasma nitrite
and nitrate species), inflammation (e.g. plasma inter-
leukin-6) and oxidative stress [e.g. nicotinamide ade-
nine dinucleotide phosphate (NADPH) oxidase
enzyme]. The chronic postprandial effects of IE fats
will also be investigated in an upcoming trial due to
begin later this year at King’s College London and
Maastricht University. The InterSat study will involve
a chronic 12-week intervention (two 6-week interven-
tion periods; 2-week run-in and 2-week washout;
16 weeks in total) to compare the health effects of
two commercially relevant IE fats, which are either
palmitic acid- or stearic acid-rich, on a wide range of
the cardiometabolic measures discussed. The estimated
potential cardiovascular public health impact of con-
suming IE fats, compared to application appropriate
Table 4 Considerations for the design of future studies on the
health effects of interesterified fats
Unknown metabolic effects of interest
• Chylomicron and VLDL lipoprotein production rate, size and remnant
clearance, including particle size distribution (e.g. proportion of small
dense LDL).
• Incorporation of sn-2 SFA into phospholipids and effects (e.g. HDL
function).
• More novel cardiometabolic risk factors: insulin sensitivity; hepatic and
other ectopic fat deposition; flow-mediated dilatation.
• Levels of inflammation (e.g. C-reactive protein, interleukin-6), oxidative
stress (e.g. NADPH oxidase) and haemostatic markers (e.g. activated
factor VII, tissue plasminogen activator, D-dimer).
Study design considerations
• Longer study duration (> 8 weeks) with well-controlled test diets
(matched for energy and fatty acid content).
• Use commercially relevant blends of IE fats consumed in the UK diet at
appropriate levels (e.g. 3–5% of dietary fat) within relevant food products
(e.g. fat spreads).
• Comparison of effects according to sex, age, ethnicity, body composition
(normal weight vs. overweight/obese) and among individuals at increased
CVD risk (e.g. those with type 2 diabetes).
Source: Mensink et al. 2016 and the Roundtable on Interesterified Fats in
Foods. CVD, cardiovascular disease; HDL, high-density lipoprotein; IE, inter-
esterified; LDL, low-density lipoprotein; NADPH, nicotinamide adenine dinu-
cleotide phosphate; SFA, saturated fatty acids; VLDL, very-low-density
lipoprotein.
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alternatives, will also be calculated in this body of
BBSRC research using data from the NDNS, expert
industry knowledge and input from collaborators
including Professor Ronald Mensink (Maastricht Univer-
sity, The Netherlands).
Building and maintaining links between nutritional
researchers and the food industry is essential to ensure
the relevance of future studies of IE fats, especially in
respect to the type of fats that are used. The BBSRC
DRINC initiative is one such example of high quality
and innovative research into diet and health resulting
from the collaboration between academia and indus-
try, and has led to the funding of the aforementioned
InterMet and InterCardio studies conducted at King’s
College London. These trials exemplify how partner-
ship working can lead to research that utilises the sci-
entific rigour and expertise of researchers, while
ensuring that findings have commercial and public
health relevance. In addition, multidisciplinary work-
shops, such as the roundtable discussed in this paper,
which bring together key stakeholders from sectors
including higher education, government departments,
public sector organisations, health services and indus-
try representatives, should also be encouraged to
increase the effectiveness with which research is con-
ducted and the findings are disseminated.
Communicating about interesterified and
other dietary fats
A review of nutrition and health research published in
2017 by the Office for Strategic Coordination of
Health Research suggested that the public’s trust in
nutrition science has been eroded in recent years and
that many people may feel confused about current
nutrition and dietary advice (MRC 2017). This may in
part be due to an over-reliance on nutrition and health
stories reported in the wider media, where the findings
from scientific studies may be exaggerated, sensation-
alised or even misreported. Taking dietary SFA as an
example, there has been recent debate about the rela-
tionship between SFA intake and CVD risk, perhaps
with insufficient acknowledgement of the need to con-
sider the nature of the nutrients replacing SFA in the
diet and the influence of the food matrix in which
SFA are consumed. Appreciation of the complexities
of the inter-relationship between dietary components
and health has led experts to suggest that more practi-
cal food-based dietary advice is needed, rather than
focusing on individual nutrients. This change in think-
ing has been summarised recently (Buttriss & Coe
2019).
While providing consumers with advice about
healthier dietary patterns is important, reformulation
of products by food manufacturers and retailers (e.g.
to decrease SFA content) is also likely to have an
important effect on longer term population health and
form a valuable part of a broader, multicomponent
public health strategy around food and nutrition. One
of the benefits of reformulation is that it does not
require people to make a conscious change in beha-
viour to benefit from the improved nutritional profile
of foods, as long as they continue to buy the reformu-
lated products. However, reformulation can be chal-
lenging for manufacturers and retailers, as while most
consumers are interested in making healthier food
choices (IGD 2019), flavour remains the strongest
determinant of food choice (Webb & Byrd-Bredbenner
2015; IFICF 2018). Maintaining palatability as well as
other important physical and sensory properties is
therefore essential.
Although IE fats have been utilised to reformulate a
number of commonly consumed food products, their
contribution to daily energy intakes remains low.
However, as an increased use of IE fats is a potential
means to decrease SFA levels in the food supply, it is
insightful to have information about public awareness
and perception of the term ‘interesterified fats’ in rela-
tion to other types of fat/fatty acids. King’s College
London and the BNF therefore commissioned a You-
Gov online survey (April 2019), which provided up-
to-date information on the attitudes of 2062 British
adults (aged over 18 years). The reported awareness
of different fat/fatty acid types among the survey
respondents is shown in Figure 8.
Figure 8 Consumer awareness of different types of dietary fat and fatty
acids from an online survey (April 2019) involving 2062 British adults.
(Source: YouGov Plc). Figures have been weighted and are representative
of all British adults (aged over 18 years). [Colour figure can be viewed at
wileyonlinelibrary.com]
© 2019 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 44, 363–380
Interesterified fats in foods 375
The survey did not gather information on people’s
understanding of these terms, although they were
asked to categorise how healthy they considered these
fats/fatty acids to be (see Table 5). A higher propor-
tion of respondents considered ‘fully hydrogenated
fats’ to be unhealthy (40%) than ‘partially hydro-
genated fats’ (32%), which indicates confusion among
consumers about the difference between these two
processes and the relative health effects of the fats
they produce. It is possible that many of the respon-
dents attached a negative connotation to the term ‘hy-
drogenation’ and assumed the ‘full’ process to be
worse than a ‘partial’ one, although it is the latter that
generates TFA.
As is evident from Figure 8, fewer respondents were
aware of ‘partially hydrogenated fats’ (34%) than
‘trans fats’ (68%) and a smaller proportion considered
them unhealthy (32%), relative to ‘trans fats’ (50%).
This suggests a lack of awareness of ‘partially hydro-
genated fats’ as a source of ‘trans fats’ among UK con-
sumers. In the US, requirements for the labelling of
TFA on food products and restrictions on the use of
partially hydrogenated oils in foods have been intro-
duced as measures to reduce TFA intakes, which are
higher than in the UK. In contrast to the situation in
the US, the voluntary reformulation by food manufac-
turers of products sold in the UK over a number of
years has led to a significant decrease in TFA intakes,
with current intakes below recommendations.
Almost a fifth of adult respondents in the survey
perceived ‘interesterified fats’ to be ‘unhealthy’ (18%),
while approximately three-quarters (73%) stated that
they ‘don’t know’, and a further 8% categorised them
as ‘neither healthy nor unhealthy’ (Table 5). This is
perhaps not surprising, as intakes of IE fats are gener-
ally low and they have not been reported in the
media. Taken together, the findings shown in Table 5
suggest understanding of the relationships between dif-
ferent types of dietary fat and health is limited.
The potential task of improving the public’s under-
standing of dietary fats in general, IE fats in particu-
lar, and the pros and cons of different reformulation
options, was discussed during the roundtable. An
important issue highlighted is the increasing popularity
of so-called ‘clean’ labels on food products (Osborn
2015). Although there is no strict definition of what
constitutes a clean label, this typically refers to prod-
ucts which contain a short list of ‘natural’ or ‘kitchen
cupboard’ ingredients, products which are free from
additives or preservatives, and those which are pro-
duced with limited processing (Asioli et al. 2017). In a
UK survey conducted in 2016, foods which were rated
by participants as more processed were viewed as
being less healthy (EUFIC 2016), although under-
standing improved when participants were provided
with scientific information on the potential benefits of
food processing, such as improved food safety and
nutritional quality.
Considering that the IE fats typically used in the UK
are palm oil-based, the relevance of negative consumer
perceptions of palm oil sustainability was discussed by
the roundtable participants. UK imports of sustainable
palm oil, supported by the Roundtable on Sustainable
Palm Oil (RSPO) certification, increased from 24% in
2009 to at least 87% in 2015 (Defra 2017). This
increase was largely the result of an industry-led com-
mitment made by various stakeholders in the palm oil
supply chain (e.g. oil processors and distributors, food
and drink manufacturers and retailers). A YouGov
survey of 1695 UK adults, conducted in March 2016,
indicated that 41% of respondents considered palm
oil to be ‘environmentally unfriendly’, a higher pro-
portion than for all other types of vegetable oil
included in the survey (e.g. 15% for ‘soybean oil’)
(Ostfeld et al. 2019). There was also very low recogni-
tion of the RSPO ‘ecolabel’ trademark (5% of respon-
dents), which can be used on products containing at
least 95% RSPO certified palm-derived components
(RSPO 2016). This may suggest that public opinion is
lagging behind progress and change in the palm oil
market.
The roundtable participants agreed that, given the
apparent confusion among consumers about the rela-
tive healthiness of different types of dietary fat (and
modification techniques used to provide functional
Table 5 Consumer perception of the healthiness of different fat
and fatty acid types from an online survey (April 2019) involving
2062 British adults
‘Healthy’
(%)
‘Unhealthy’
(%)
‘neither
healthy nor
unhealthy’
(%)
‘Don't
know’
(%)
Interesterified fats 1 18 8 73
Partially hydrogenated fats 2 32 18 48
Saturated fats 3 69 10 19
Fully hydrogenated fats 3 40 13 44
Trans fats 4 50 13 33
Monounsaturated fats 17 23 17 43
Polyunsaturated fats 29 17 20 34
Omega-3 85 1 5 9
Source: YouGov Plc. Figures have been weighted and are representative of
all British adults (aged 18+ years).
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fats, such as hydrogenation), it would be pertinent to
prioritise communication between scientists, health-
care professionals and non-specialists in the food
industry, to ensure a consistent knowledge of the
interesterification process, and the evidence to date on
the health effects of IE fats. Members of the roundta-
ble also highlighted the following points for considera-
tion before any future wider communication to the
general public about IE fats.
• There is a need to understand better consumers’
attitudes and information needs with respect to inter-
esterification and other commonly used food process-
ing techniques, including whether there is a less
technical term that could be used for IE fats (e.g.
‘mixed’ or ‘random’ fats). This could be achieved
through the use of surveys (as reported here) or con-
sumer focus groups.
• As the acceptance of processed foods may increase
when consumers are given information on the poten-
tial benefits of food processing (e.g. improved food
safety and enhanced nutritional profile), highlighting
the benefits of using interesterification as a food tech-
nology (removal of TFA and reduction in SFA con-
tent) could help consumers to form a balanced
opinion of the use of IE fats. However, it was agreed
that more research is needed on the longer-term health
effects of commercially available IE fat products.
• Communication about IE fats could provide an
opportunity for food manufacturers to build trust with
their consumers through information about how food
products are produced, and the reasons for using par-
ticular processing technologies.
• Concise summary information for non-technical
staff within food businesses may be useful.
• Enzymatic interesterification of fat occurs in the
body during the production of human breast milk
(Miles & Calder 2017). This could be utilised as an
example of ‘natural’ interesterification to explain the
process to consumers.
• Research to date on the metabolic effects of IE fats
indicates a ‘neutral’ effect on cardiometabolic risk,
although further long-term human studies of commer-
cially relevant IE fats are needed. This could present a
challenge for communication, as public uptake of
nutrition messages is generally better if they carry a
specific ‘doable’ recommendation (Webb & Byrd-
Bredbenner 2015).
• There is no legal requirement to specify the use of
an IE fat as an ingredient on the label of a food prod-
uct. The roundtable participants agreed that, at pre-
sent, there is no scientific evidence to suggest that this
would be useful information for the consumer. How-
ever, focusing communication on stakeholders in the
food industry, those working in public health and
other healthcare professionals, would increase the level
of understanding of interesterification, should any con-
sumer concerns arise in future.
Conclusion
Interesterification is a technique that provides fats
which can be used in a range of food applications. It
is one of a number of reformulation approaches that
have enabled the removal of partially hydrogenated
fats and ‘industrial’ TFA from the food chain, without
altering key product characteristics such as flavour
and cost. The use of IE fats can also result in a final
product with a lower SFA content, in comparison
with using the currently available non-IE alternatives.
The novel data presented in this paper indicate that
daily intakes of IE fats are relatively small among UK
consumers (about 1% of daily energy intake on aver-
age). There is the potential to increase their use in
certain product categories (e.g. cakes and biscuits).
Further reformulation of these product types could
potentially contribute to reducing population intakes
of SFA, alongside recommendations to encourage
healthier dietary choices. However, achieving this
would depend on the amount and frequency with
which IE-containing products are consumed by differ-
ent groups within the population. The limited
research to date in humans suggests no adverse effects
of consuming IE fats on cardiometabolic risk, and
longer term studies using commercially relevant IE
fats are underway.
Results from the survey presented in this paper indi-
cate confusion about the health effects of dietary fats
among the UK public. This offers an opportunity to
provide the public with factual information about
dietary fats and health, as well as the reformulation
options and new technologies that are being employed
to improve the fatty acid profile of many food prod-
ucts. Such an approach might be an important public
engagement strategy to enable better understanding of
the science around dietary fats and health, and the
reformulation journey that has been under way for
some decades, geared to improving public health.
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